Publication | Open Access

Final results of a multicenter phase II study of the purine nucleoside phosphorylase (PNP) inhibitor forodesine in patients with advanced cutaneous t-cell lymphomas (CTCL) (Mycosis fungoides and Sézary syndrome)

Lymphoid NeoplasiaMedicineImmunodeficienciesImmunologyPathologyClinical DermatologyInhibitor ForodesineDermatologyDermatopathologySclerodermaImmunotherapyAdult T-cell Leukemia-lymphomaMycosis FungoidesFinal Results